Esperion Therapeutics, Inc. financial data

Symbol
ESPR on Nasdaq
Location
Ann Arbor, MI
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 116% % -37%
Quick Ratio 35% % -23%
Debt-to-equity -181% % 2.1%
Return On Equity 25% % 5%
Return On Assets -31% % -10%
Operating Margin -10% % -274%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 239,063,437 shares 21%
Entity Public Float $435,100,000 USD 205%
Common Stock, Value, Issued $205,000 USD 5.1%
Weighted Average Number of Shares Outstanding, Basic 200,736,136 shares 3%
Weighted Average Number of Shares Outstanding, Diluted 200,736,136 shares 3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $303,802,000 USD 2.8%
Operating Income (Loss) $29,380,000 USD -279%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $105,831,000 USD -22%
Earnings Per Share, Basic 0 USD/shares -11%
Earnings Per Share, Diluted 0 USD/shares -3.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $92,447,000 USD -36%
Accounts Receivable, after Allowance for Credit Loss, Current $118,980,000 USD 75%
Inventory, Net $108,539,000 USD 36%
Assets, Current $360,464,000 USD 17%
Property, Plant and Equipment, Net $175,000 USD -38%
Operating Lease, Right-of-Use Asset $3,325,000 USD -47%
Assets $364,020,000 USD 16%
Accounts Payable, Current $77,513,000 USD 122%
Employee-related Liabilities, Current $9,814,000 USD -12%
Contract with Customer, Liability, Current $30,679,000 USD 103%
Liabilities, Current $359,033,000 USD 116%
Operating Lease, Liability, Noncurrent $767,000 USD -77%
Other Liabilities, Noncurrent $7,436,000 USD
Liabilities $815,381,000 USD 19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $1,685,542,000 USD -6.7%
Stockholders' Equity Attributable to Parent $451,361,000 USD -22%
Liabilities and Equity $364,020,000 USD 16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,628,000 USD -142%
Net Cash Provided by (Used in) Financing Activities $7,500,000 USD -108%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 480,000,000 shares 0%
Common Stock, Shares, Issued 207,424,417 shares 5.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $30,128,000 USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $92,447,000 USD -36%
Deferred Tax Assets, Valuation Allowance $413,085,000 USD 4.4%
Deferred Tax Assets, Gross $414,606,000 USD 4.5%
Operating Lease, Liability $5,311,000 USD 16%
Depreciation $26,000 USD
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $105,831,000 USD -22%
Lessee, Operating Lease, Liability, to be Paid $5,753,000 USD 13%
Property, Plant and Equipment, Gross $2,328,000 USD 16%
Operating Lease, Liability, Current $2,384,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,307,000 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,061,000 USD 67%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $442,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $241,000 USD -79%
Deferred Tax Assets, Operating Loss Carryforwards $203,889,000 USD -21%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $2,099,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $144,000 USD -15%
Additional Paid in Capital $1,288,974,000 USD 2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $10,288,000 USD -22%
Interest Expense $58,613,000 USD 2.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%